Name: UMIN ID:
Unique ID issued by UMIN | UMIN000009035 |
---|---|
Receipt number | R000010602 |
Scientific Title | Phase II study of neoadjuvant chemotherapy with nab-Paclitaxel followed by EC for resectable primary breast cancer |
Date of disclosure of the study information | 2012/10/03 |
Last modified on | 2020/04/09 09:14:11 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/10/03 17:56:33 | ||
2 | Update | 2014/10/03 17:20:37 | TEL TEL Organization Organization |
|
3 | Update | 2014/10/03 17:40:09 | Last follow-up date |
|
4 | Update | 2019/10/09 12:05:50 | Date of IRB Date analysis concluded |
|
5 | Update | 2020/04/09 09:14:11 | Recruitment status Date of closure to data entry Date trial data considered complete |